Publication | Closed Access

Novel 4,4-bis(trifluoromethyl) imidazolines as stereospecific and orally active acyl coa: Cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents

Combinatorial ChemistryMedicinal ChemistryActive Acyl CoaBiochemistryNatural SciencesMedicineCholesterol AcyltransferaseAntihypercholesterolemic AgentsPharmacologyPharmaceutical ChemistryDrug Discovery